CYP2A6 and colitis: On the other hand, in GF mice, DSS-induced colitis (DSS, group 2) led to a slight increase in CYP2A activity compared to control mice (CT, group 1) and the administration of SB prior to DSS (SB + DSS, group 3) did not change this phenomenon (Figure 2A).